Protein cages and virus-like particles: from fundamental insight to biomimetic therapeutics.

Protein cages (viral and non-viral) found in nature have evolved for a variety of purposes and are found in all kingdoms of life. The main functions of these nanoscale compartments are the protection and delivery of nucleic acids e.g. virus capsids, or the enrichment and sequestration of metabolons e.g. bacterial microcompartments. This review focuses on recent developments of protein cages for use in immunotherapy and therapeutic delivery. In doing so, we highlight the unique ways in which protein cages have informed on fundamental principles governing bio-nano interactions. With the enormous existing design space among naturally occurring protein cages, there is still much to learn from studying them as biomimetic particles.

[1]  Matthias Müller,et al.  Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode. , 2019, Nano letters.

[2]  N. Steinmetz,et al.  Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. , 2014, Nanomedicine.

[3]  A. Rynda-Apple,et al.  Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent , 2017, mBio.

[4]  Cher Heng Tan,et al.  Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells , 2015 .

[5]  P. Savard,et al.  Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[6]  N. Steinmetz,et al.  In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma. , 2018, Molecular pharmaceutics.

[7]  G. Jennings,et al.  A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity , 2005, European journal of immunology.

[8]  M. Agbandje-McKenna,et al.  Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles , 2018, PLoS pathogens.

[9]  R. Twyman,et al.  Virus-based nanoparticles as platform technologies for modern vaccines. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[10]  F. Kratz,et al.  Engineered drug-protein nanoparticle complexes for folate receptor targeting. , 2014, Biochemical engineering journal.

[11]  Rees F. Garmann,et al.  Reconstituted plant viral capsids can release genes to mammalian cells. , 2013, Virology.

[12]  David Baker,et al.  Accurate design of megadalton-scale two-component icosahedral protein complexes , 2016, Science.

[13]  Trevor Douglas,et al.  Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery , 2015, Journal of Nanobiotechnology.

[14]  Sierin Lim,et al.  Design of a pH-dependent molecular switch in a caged protein platform. , 2009, Nano letters.

[15]  J. Cornelissen,et al.  Structural Characterization of Native and Modified Encapsulins as Nanoplatforms for in Vitro Catalysis and Cellular Uptake , 2017, ACS nano.

[16]  M. Croyle,et al.  PEGylated Adenoviruses: From Mice to Monkeys , 2010, Viruses.

[17]  E. Nelson,et al.  Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses. , 2016, Biomaterials.

[18]  D. Hilvert,et al.  Laboratory evolution of virus-like nucleocapsids from nonviral protein cages , 2018, Proceedings of the National Academy of Sciences.

[19]  P. Silver,et al.  Widespread distribution of encapsulin nanocompartments reveals functional diversity , 2017, Nature Microbiology.

[20]  Christopher M. Jakobson,et al.  Quantitative characterization of all single amino acid variants of a viral capsid-based drug delivery vehicle , 2018, Nature Communications.

[21]  S. Boulant,et al.  Dynamics of Virus-Receptor Interactions in Virus Binding, Signaling, and Endocytosis , 2015, Viruses.

[22]  D. Hilvert,et al.  A simple tagging system for protein encapsulation. , 2006, Journal of the American Chemical Society.

[23]  E. Nelson,et al.  Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells. , 2017, ACS biomaterials science & engineering.

[24]  P. Lizotte,et al.  In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer , 2015, Nature nanotechnology.

[25]  A. Levine,et al.  Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers. , 2017, Biomaterials.

[26]  Xin Yu,et al.  Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging. , 2019, ACS applied materials & interfaces.

[27]  F. Sainsbury,et al.  Programmable In Vitro Coencapsidation of Guest Proteins for Intracellular Delivery by Virus-like Particles. , 2018, ACS nano.

[28]  Daniel Luque,et al.  Assembling Enzymatic Cascade Pathways inside Virus-Based Nanocages Using Dual-Tasking Nucleic Acid Tags , 2017, Journal of the American Chemical Society.

[29]  Gary Siuzdak,et al.  Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin , 2009, PLoS pathogens.

[30]  D. Hilvert,et al.  Diffusion-Limited Cargo Loading of an Engineered Protein Container. , 2015, Journal of the American Chemical Society.

[31]  P. Pisa,et al.  Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages1 , 2009, The Journal of Immunology.

[32]  V. Muzykantov,et al.  Ferritin‐based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[33]  M. Bachmann,et al.  Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen , 2012, The Journal of Immunology.

[34]  G. Saidel,et al.  Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio. , 2016, The journal of physical chemistry. B.

[35]  A. Heck,et al.  Structure and assembly of scalable porous protein cages , 2017, Nature Communications.

[36]  P. Savard,et al.  Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles. , 2016, Nano letters.

[37]  M. Hashizume,et al.  Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. , 2015, Molecular pharmaceutics.

[38]  Wilfred Chen,et al.  Sortase A-mediated multi-functionalization of protein nanoparticles. , 2015, Chemical communications.

[39]  D. Speiser,et al.  Virus‐like particles for vaccination against cancer , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[40]  Yuehe Lin,et al.  Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery. , 2015, Biomaterials science.

[41]  P. Mali,et al.  immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy , 2019, Nature Biomedical Engineering.

[42]  V. Kickhoefer,et al.  Targeting vault nanoparticles to specific cell surface receptors. , 2009, ACS nano.

[43]  G. Wang,et al.  A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism , 2019, Proceedings of the National Academy of Sciences.

[44]  N. Steinmetz,et al.  The Aspect Ratio of Nanoparticle Assemblies and the Spatial Arrangement of Ligands can be Optimized to Enhance the Targeting of Cancer Cells , 2014, Advanced healthcare materials.

[45]  J. Heddle,et al.  Natural and artificial protein cages: design, structure and therapeutic applications. , 2017, Current opinion in structural biology.

[46]  D. Lauffenburger,et al.  Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design , 2000, Biotechnology and bioengineering.

[47]  Emily C. Hartman,et al.  A Selection for Assembly Reveals That a Single Amino Acid Mutant of the Bacteriophage MS2 Coat Protein Forms a Smaller Virus-like Particle. , 2016, Nano letters.

[48]  Jennifer E. Padilla,et al.  Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Nicole F Steinmetz,et al.  Design of virus-based nanomaterials for medicine, biotechnology, and energy. , 2016, Chemical Society reviews.

[50]  T. Giessen.  Encapsulins: microbial nanocompartments with applications in biomedicine, nanobiotechnology and materials science. , 2016, Current opinion in chemical biology.

[51]  Colin R. Parrish,et al.  Limited Transferrin Receptor Clustering Allows Rapid Diffusion of Canine Parvovirus into Clathrin Endocytic Structures , 2012, Journal of Virology.

[52]  A. Sloan,et al.  Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy , 2019, Cancers.

[53]  N. Steinmetz,et al.  Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles. , 2019, Biomaterials science.

[54]  N. Steinmetz,et al.  Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response. , 2017, Nano letters.

[55]  P. Prevelige,et al.  Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22. , 2011, Angewandte Chemie.

[56]  Donald Hilvert,et al.  Directed Evolution of a Protein Container , 2011, Science.

[57]  D. Stuart,et al.  Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine , 2017, Nature Communications.

[58]  Zhi-ping Zhang,et al.  Role of Surface RGD Patterns on Protein Nanocages in Tumor Targeting Revealed Using Precise Discrete Models. , 2019, Small.

[59]  J. V. van Hest,et al.  Versatile Reversible Cross-Linking Strategy to Stabilize CCMV Virus Like Particles for Efficient siRNA Delivery , 2019, Bioconjugate chemistry.

[60]  Frank A. Veliz,et al.  Endosomal toll‐like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus , 2019, Immunology.

[61]  T. Storni,et al.  Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison , 2004, The Journal of Immunology.

[62]  R. Gillies,et al.  Effects of linker length and flexibility on multivalent targeting. , 2008, Biomacromolecules.

[63]  B. Guy,et al.  Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults , 2019, PloS one.

[64]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[65]  Sebyung Kang,et al.  Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform. , 2014, Biomacromolecules.

[66]  N. Steinmetz,et al.  Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. , 2011, Nanomedicine.

[67]  H. Jung,et al.  Engineering Tunable Dual Functional Protein Cage Nanoparticles Using Bacterial Superglue. , 2018, Biomacromolecules.

[68]  David Baker,et al.  Evolution of a designed protein assembly encapsulating its own RNA genome , 2017, Nature.

[69]  Arun Srivastava,et al.  In vivo tissue-tropism of adeno-associated viral vectors. , 2016, Current opinion in virology.

[70]  N. Steinmetz,et al.  Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine. , 2019, Journal of the American Chemical Society.

[71]  K. Schwarz,et al.  Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.

[72]  M. Manchester,et al.  Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions. , 2012, Nanomedicine.

[73]  Xiaoyuan Chen,et al.  Functional ferritin nanoparticles for biomedical applications , 2017, Frontiers of Chemical Science and Engineering.

[74]  Hyungjoon Cho,et al.  Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI , 2015, Scientific Reports.

[75]  T. Douglas,et al.  Modular interior loading and exterior decoration of a virus-like particle. , 2017, Nanoscale.

[76]  A. Heck,et al.  Self-sorting of foreign proteins in a bacterial nanocompartment. , 2014, Journal of the American Chemical Society.

[77]  Sierin Lim,et al.  Cyclodextrin conjugated ferritin nanocages reduce intracellular cholesterol level in foam cells , 2019, Nano Research.

[78]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[79]  A. Rynda-Apple,et al.  Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. , 2013, ACS nano.

[80]  Fabian J. Eber,et al.  The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft‐Matter Nanorods , 2015, Advanced healthcare materials.

[81]  M. Young,et al.  Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.

[82]  Kathleen L Hefferon,et al.  Repurposing Plant Virus Nanoparticles , 2018, Vaccines.

[83]  D. Baker,et al.  Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy , 2012, Science.

[84]  G. Lomonossoff,et al.  Engineering Recombinant Virus-like Nanoparticles from Plants for Cellular Delivery. , 2017, ACS nano.

[85]  Sierin Lim,et al.  Engineering protein nanocages as carriers for biomedical applications , 2017, NPG Asia materials.

[86]  In‐San Kim,et al.  Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity. , 2013, ACS nano.

[87]  B. Jiang,et al.  GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy , 2019, Theranostics.

[88]  D. Hilvert,et al.  Diversification of Protein Cage Structure Using Circularly Permuted Subunits. , 2018, Journal of the American Chemical Society.

[89]  J. Cornelissen,et al.  Structural nanotechnology: three-dimensional cryo-EM and its use in the development of nanoplatforms for in vitro catalysis. , 2019, Nanoscale.

[90]  M. Bachmann,et al.  Major findings and recent advances in virus-like particle (VLP)-based vaccines. , 2017, Seminars in immunology.

[91]  J. Mast,et al.  Simultaneous surface display and cargo loading of encapsulin nanocompartments and their use for rational vaccine design. , 2018, Vaccine.

[92]  N. Molino,et al.  Caged protein nanoparticles for drug delivery. , 2014, Current opinion in biotechnology.

[93]  Yang Yang,et al.  Glioma targeting peptide modified apoferritin nanocage , 2018, Drug delivery.

[94]  T. Douglas,et al.  Cargo Retention inside P22 Virus-Like Particles. , 2018, Biomacromolecules.

[95]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[96]  Hayley K Charlton Hume,et al.  Synthetic biology for bioengineering virus‐like particle vaccines , 2018, Biotechnology and bioengineering.

[97]  David Baker,et al.  Design of a hyperstable 60-subunit protein icosahedron , 2016, Nature.

[98]  L. BenMohamed,et al.  Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. , 2015, ACS chemical biology.

[99]  Frank A. Veliz,et al.  Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation. , 2018, Molecular pharmaceutics.